PROCEPT BioRobotics holder plans sale of 297 shares

A PRCT stockholder filed a Rule 144 notice to sell 297 recently vested compensation shares, partly to cover related tax obligations.

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp (PRCT) had a Form 144 filed on behalf of stockholder Alaleh Nouri indicating an intended sale of 297 shares of common stock through Fidelity Brokerage Services LLC on or after September 9, 2026, under Rule 144.

The shares relate to a restricted stock vesting event on September 8, 2026, received from the issuer as compensation. The filer notes that the sale includes an amount necessary to cover a tax obligation arising from settlement of the vested equity award. Reported outstanding common shares total 57,273,659.

Key Figures

Shares to be sold: 297 shares Aggregate market value of shares to be sold: $6,223.10 Shares outstanding: 57,273,659 shares +2 more

5 metrics

Shares to be sold 297 shares Common stock intended for sale under Rule 144 through Fidelity Brokerage Services LLC

Aggregate market value of shares to be sold $6,223.10 Value of 297 PRCT common shares covered by the Form 144 notice

Shares outstanding 57,273,659 shares Common shares outstanding as listed in the Form 144 securities information table

Approximate date of sale September 9, 2026 Approximate date the 297 PRCT shares may be sold under Rule 144

Date of restricted stock vesting September 8, 2026 Date the 297 common shares were acquired via restricted stock vesting as compensation

Key Terms

Rule 144, Restricted Stock Vesting, equity award distribution, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 09/08/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

equity award distribution financial

"resulting from the settlement of a vested equity award distribution."

aggregate market value financial

"297 | 6223.10 | 57273659 | 09/09/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing for PRCT disclose about the planned stock sale?

The Form 144 discloses that 297 shares of PROCEPT BioRobotics Corp common stock are intended to be sold through Fidelity Brokerage Services LLC on or after September 9, 2026 under Rule 144.

Who is the PRCT stockholder involved in this Form 144 filing?

The notice is filed for the account of Alaleh Nouri, with Fidelity Brokerage Services LLC acting as broker and signing as attorney-in-fact for the stockholder.

How many PROCEPT BioRobotics Corp (PRCT) shares are outstanding in this Form 144?

The Form 144 table lists 57,273,659 shares of PROCEPT BioRobotics Corp common stock as outstanding in connection with the Rule 144 disclosure.

What is the value of the PRCT shares covered by this Form 144 notice?

The Form 144 reports an aggregate market value of approximately $6,223.10 for the 297 shares of PROCEPT BioRobotics Corp common stock intended to be sold.

Why are the PRCT shares being sold according to the Form 144 remarks?

The remarks state that the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution related to the restricted stock vesting.

When and how were the PRCT shares in this Form 144 acquired?

The 297 common shares were acquired on September 8, 2026 through Restricted Stock Vesting from the issuer as compensation, as described in the Form 144 acquisition information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 03:16 PM Accepted by SEC EDGAR 09/09/2026 - 03:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001599418
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PROCEPT BioRobotics Corp
SEC File Number	001-40797
Address of Issuer	150 BAYTECH DRIVE SAN JOSE CALIFORNIA 95134
Phone	6502329832
Name of Person for Whose Account the Securities are To Be Sold	Nouri Alaleh
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	297	6223.10	57273659	09/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/08/2026	Restricted Stock Vesting	Issuer			297	09/08/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Alaleh Nouri
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)